Dear Editor,
Colonization of H.pylori as a bacterial pathogen in the stomach can cause a number of gastric diseases, such as peptic ulcers, chronic gastritis and gastric cancer (1, 2). Over the past years, a series of systemic diseases has been reported to be potentially related to H. pylori infection, including cardiovascular, neurologic, hepatobiliary, dermatologic, endocrine and metabolic, immunologic, respiratory and urogenital diseases (3-6).
Hematologic disorders were other extragastric manifestations of H. pylori. Several studies presented that H. pylori can be a causative factor for anemia, iron deficiency and iron deficiency anemia (IDA) (3, 7, 8). In addition, it was stated that eradication of this pathogen not only led to increase in response to oral iron therapy and level of ferritin, but also could cure anemia completely in several cases with unexplained IDA (5, 8, 9). Idiopathic thrombocytopenic purpura (ITP) is the other hematologic disease shown to be related to infection of H. pylori. It was reported that treatment of the infection was associated with increased platelet count in some patients with ITP. Modulation of Fcγ-receptor balance of monocytes or macrophages, and mimicry of platelet antigens by H. pylori peptides are putative mechanisms explaining the relation between ITP and this infection (9). It was also proposed that H. pylori-induced gastritis could be a leading factor of vitamin B12 deficiency in patients (10). Altogether, ITP is considered as an accepted hematologic manifestation of H. pylori infection. Besides, it seems that the infection can possibly decrease level of iron storage, resulting in IDA. Therefore, H. pylori treatment can be indicated in patients with IDA, ITP and vitamin B12 deficiency.
Conflict of interest
None declared.
References
- 1.Khedmat H, Karbasi-Afshar R, Agah S, Taheri S. Helicobacter pylori Infection in the general population: A Middle Eastern perspective. Caspian J Intern Med. 2013;4:745–53. [PMC free article] [PubMed] [Google Scholar]
- 2.Tokudome S, Ghadimi R, Suzuki S, et al. Helicobacter pylori infection appears the prime risk factor for stomach cancer. Int J Cancer. 2006;119:2991. doi: 10.1002/ijc.22223. [DOI] [PubMed] [Google Scholar]
- 3.Goni E, Franceschi F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016;21:45–8. doi: 10.1111/hel.12340. [DOI] [PubMed] [Google Scholar]
- 4.Sotuneh N, Hosseini SR, Shokri-Shirvani J, Bijani A, Ghadimi R. Helicobacter pylori infection and metabolic parameters: is there an association in elderly population? Int J Prev Med. 2014;5:1537–42. [PMC free article] [PubMed] [Google Scholar]
- 5.Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter. 2013;18:44–51. doi: 10.1111/hel.12077. [DOI] [PubMed] [Google Scholar]
- 6.Robinson K. Helicobacter pylori-mediated protection against extra-gastric immune and inflammatory disorders: the evidence and controversies. Diseases. 2015;3:34–55. doi: 10.3390/diseases3020034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Qujeq D, Sadogh M, Savadkohi S. Association between helicobacter pylori infection and serum iron profile. Caspian J Intern Med. 2011;2:266–9. [PMC free article] [PubMed] [Google Scholar]
- 8.Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta‐analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22 doi: 10.1111/hel.12330. doi: 10.1111/hel.12330. [DOI] [PubMed] [Google Scholar]
- 9.Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and extragastric diseases. Helicobacter. 2014;19:52–8. doi: 10.1111/hel.12159. [DOI] [PubMed] [Google Scholar]
- 10.Kuo CH, Chen YH, Goh KL, Chang LL. Helicobacter pylori and systemic disease. Gastroenterol Res Prac. 2014;2014:358494. doi: 10.1155/2014/358494. [DOI] [PMC free article] [PubMed] [Google Scholar]